These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15651915)

  • 1. Neurotoxicology: principles and considerations of in vitro assessment.
    Aschner M; Syversen T
    Altern Lab Anim; 2004 Oct; 32(4):323-7. PubMed ID: 15651915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity testing: a discussion of in vitro alternatives.
    Costa LG
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):505-10. PubMed ID: 9599699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral toxicology, risk assessment, and chlorinated hydrocarbons.
    Evangelista de Duffard AM; Duffard R
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):353-60. PubMed ID: 9182042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New animal-free concepts and test methods for developmental toxicity and peripheral neurotoxicity.
    Leist M
    Altern Lab Anim; 2017 Nov; 45(5):253-260. PubMed ID: 29112453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.
    Schmidt BZ; Lehmann M; Gutbier S; Nembo E; Noel S; Smirnova L; Forsby A; Hescheler J; Avci HX; Hartung T; Leist M; Kobolák J; Dinnyés A
    Arch Toxicol; 2017 Jan; 91(1):1-33. PubMed ID: 27492622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECVAM and new technologies for toxicity testing.
    Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
    Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of neurotoxic potential by use of in vitro systems.
    Harry GJ; Tiffany-Castiglioni E
    Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):701-13. PubMed ID: 16863434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Especial considerations for neurotoxicological research.
    Bondy SC
    Crit Rev Toxicol; 1985; 14(4):381-402. PubMed ID: 2414065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs.
    Bal-Price AK; Suñol C; Weiss DG; van Vliet E; Westerink RH; Costa LG
    Neurotoxicology; 2008 May; 29(3):520-31. PubMed ID: 18417220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered.
    Bal-Price AK; Hogberg HT; Buzanska L; Coecke S
    Neurotoxicol Teratol; 2010; 32(1):36-41. PubMed ID: 19150401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
    Terron A; Bennekou SH
    Toxicol Appl Pharmacol; 2018 Sep; 354():19-23. PubMed ID: 29454059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated testing strategies for toxicity employing new and existing technologies.
    Combes RD; Balls M
    Altern Lab Anim; 2011 Jul; 39(3):213-25. PubMed ID: 21777036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicology in regulation and risk assessment.
    Reiter LW
    Dev Pharmacol Ther; 1987; 10(5):354-68. PubMed ID: 3308380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian wildlife as complementary models in environmental neurotoxicology.
    Basu N; Head J
    Neurotoxicol Teratol; 2010; 32(1):114-9. PubMed ID: 19602387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-first century challenges for in vitro neurotoxicity.
    Smith RA
    Altern Lab Anim; 2009 Sep; 37(4):367-75. PubMed ID: 19807209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell culture models for neurotoxicology.
    Stacey G; Viviani B
    Cell Biol Toxicol; 2001; 17(4-5):319-34. PubMed ID: 11768597
    [No Abstract]   [Full Text] [Related]  

  • 18. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
    Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
    Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants.
    Hoelting L; Klima S; Karreman C; Grinberg M; Meisig J; Henry M; Rotshteyn T; Rahnenführer J; Blüthgen N; Sachinidis A; Waldmann T; Leist M
    Stem Cells Transl Med; 2016 Apr; 5(4):476-87. PubMed ID: 26933043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of developmental neurotoxicology studies in risk assessment.
    Tilson HA
    Toxicol Pathol; 2000; 28(1):149-56. PubMed ID: 10669002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.